Literature DB >> 1835127

Effects of castration, Depo-testosterone and cyproterone acetate on lymphocyte T subsets in mouse thymus and spleen.

S Aboudkhil1, J P Bureau, L Garrelly, P Vago.   

Abstract

The effects of testosterone on the relative proportion of Thy 1.2, CD4 (L3T4) and CD8 (Lyt-2) cells in thymus and spleen were studied after castration and administration of Depo-testosterone (DT) separately or together with cyproterone acetate (CA) (an antiandrogen) in BDF1 mice. Injection of 0.5 mg/100 g body weight of DT during 2 weeks decreased significantly the number and proportion of double positive (DP) (CD4+ CD8+) and increased the percentage of single positive (SP) CD4+ (CD4+ CD8-), whereas there was a slight decrease in the Thy 1.2+ cells in the thymus. In parallel, we observed an increase in CD8+ (CD4- CD8+) cells in the spleen. The androgen deprivation after 3 weeks of castration induced a decrease in the percentage of CD4+ cells in thymus and both CD4+ and CD8+ cells in spleen. Injection of CA (0.5 mg/100 g body weight) had the same qualitative effects as DT on the proportion of lymphocyte T subsets in castrated mice. However, the combined activities of DT and CA were greater than either alone. These data indicate the main role of testosterone in the distribution of CD4+ and CD8+ cells in male mice. The similar effects of CA and DT in the lymphoid organs may suggest a difference between androgen receptors of sexual and lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835127     DOI: 10.1111/j.1365-3083.1991.tb01588.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus.

Authors:  M C Erlandsson; C Ohlsson; J A Gustafsson; H Carlsten
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

2.  The effect of testosterone replacement treatment on immunological features of patients with Klinefelter's syndrome.

Authors:  I H Koçar; Z Yesilova; M Ozata; M Turan; A Sengül; I Ozdemir
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

3.  Gonadotropin treatment restores in vitro interleukin-1beta and tumour necrosis factor-alpha production by stimulated peripheral blood mononuclear cells from patients with idiopathic hypogonadotropic hypogonadism.

Authors:  U Musabak; E Bolu; M Ozata; C Oktenli; A Sengul; A Inal; Z Yesilova; G Kilciler; I C Ozdemir; I H Kocar
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 4.  Androgen-Induced Immunosuppression.

Authors:  Melanie R Gubbels Bupp; Trine N Jorgensen
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

Review 5.  Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered.

Authors:  A Losada-García; S A Cortés-Ramírez; M Cruz-Burgos; M Morales-Pacheco; Carlos D Cruz-Hernández; Vanessa Gonzalez-Covarrubias; Carlos Perez-Plascencia; M A Cerbón; M Rodríguez-Dorantes
Journal:  Front Genet       Date:  2022-01-17       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.